Results 21 to 30 of about 609,006 (169)

Genetic Therapy of Fuchs Endothelial Corneal Dystrophy: Where Are We? A Review. [PDF]

Genes (Basel)
Objectives: The incidence of Fuchs endothelial corneal dystrophy (FECD) is growing, and with it, the unmet need for a corneal transplant. Among alternative treatment modalities, only genetic therapy represents a causal therapy.
Stunf Pukl S.
europepmc   +2 more sources

Emerging Innovations in the Treatment of Fuchs Endothelial Corneal Dystrophy: A Narrative Review. [PDF]

Med Sci (Basel)
Fuchs endothelial corneal dystrophy (FECD) is the leading cause of endothelial failure requiring keratoplasty in industrialised nations. Descemet membrane endothelial keratoplasty (DMEK) has become the gold-standard surgical therapy, yet it is ...
Niestrata M, Jackson J, Bazeer S, Gong MA, Ashena Z.   +4 more
europepmc   +2 more sources

Fuchs endothelial corneal dystrophy and keratoconus: A very rare coincidence [PDF]

, 2023
It was aimed to represent a case with concurrent Fuchs endothelial corneal dystrophy (FECD) and keratoconus (KC) as a rare entity. A 35-year-old woman had a best-corrected visual acuity was 20/20 in the right eye and 20/60 in the left eye (Snellen ...
Ibrahim Toprak, Deniz Kılıç, Emre Güneş   +2 more
core   +2 more sources

Fuchs’ endothelial corneal dystrophy RNA sequencing datasets for meta-analysis.

, 2023
Fuchs’ endothelial corneal dystrophy RNA sequencing datasets for meta-analysis.
V. Vinod Mootha (6264278), Ashwani Kumar (55732), Xunzhi Zhang (14631644), Adwait A. Sathe (6541643), Chao Xing (28961)   +4 more
core   +1 more source

Additional file 2 of A 20-year bibliometric analysis of Fuchs endothelial corneal dystrophy: from 2001 to 2020

, 2022
Additional file 2: Supplementary Figure 1. Contributions of different countries to FECD research.
Yuliang Wang (437561), Luoli Zhang (12841826), Yimin Wang (724389), Feng Lin (23861), Xingtao Zhou (441471), Dan Fu (1323018)   +5 more
core   +1 more source

MicroRNA of Epithelial to Mesenchymal Transition in Fuchs’ Endothelial Corneal Dystrophy

, 2022
Aim: a review of miRNA expression connected to epithelial mesenchymal transition studies in Fuchs’ endothelial corneal dystrophy (FECD). Methods: literature search strategy—PubMed central database, using “miRNA” or “microRNA&
Stunf Pukl, Spela, Spela Stunf Pukl
core   +1 more source

Shared modules of gene co-expression networks in Fuchs’ endothelial corneal dystrophy (FECD) patients with (RE+) and without (RE-) the TCF4 CTG18.1 expansion.

, 2023
Shared modules of gene co-expression networks in Fuchs’ endothelial corneal dystrophy (FECD) patients with (RE+) and without (RE-) the TCF4 CTG18.1 expansion.
V. Vinod Mootha (6264278), Ashwani Kumar (55732), Xunzhi Zhang (14631644), Adwait A. Sathe (6541643), Chao Xing (28961)   +4 more
core   +1 more source

Femtosecond Laser-Assisted Cataract Surgery: Does It Improve Outcomes in Fuchs Endothelial Corneal Dystrophy?

, 2020
The role of femtosecond laser -assisted cataract surgery in patients with Fuchs endothelial corneal dystrophy remains poorly defined.
Koo, Ellen H, Ellen H. Koo
core   +1 more source

Cataract surgery in patients with Fuchs’ dystrophy and corneal decompensation indicated for Descemet's membrane endothelial keratoplasty

Scientific Reports, 2022
The availability of corneal donor tissue is limited in most developing countries. This study evaluated whether patients with coexisting cataract and Fuchs’ dystrophy with corneal decompensation awaiting Descemet’s membrane endothelial keratoplasty (DMEK)
Wei-Yi Chou, Yih-Shiuan Kuo, Pei-Yu Lin
doaj   +1 more source

Expression and Function of ZEB1 in the Cornea

Cells, 2021
ZEB1 is an important transcription factor for epithelial to mesenchymal transition (EMT) and in the regulation of cell differentiation and transformation.
Yingnan Zhang, Xiao Liu, Wei Liang, Douglas C. Dean, Lijun Zhang, Yongqing Liu   +5 more
doaj   +1 more source